Table 5.
Maximum aortic diameter measurements and disease progression in the follow up cohort (n = 15)
| Parameters | Baseline | 1-year follow up | ||||
|---|---|---|---|---|---|---|
| CTA | CMRA | ICC | CTA | CMRA | ICC | |
| Ascending aorta dilatation | ||||||
| Maximum diameter (mm) | 44.5 ± 2.7 | 44.5 ± 2.6 | 0.98 | 45.3 ± 3.3 | 45.3 ± 3.1 | 0.99 |
| Progression (mm) | 0.7 ± 1.7 | 0.8 ± 1.8 | 0.90 | |||
| Progression (%) | 1.6 ± 3.5 | 1.7 ± 3.8 | 0.89 | |||
| Descending aorta dilatation | ||||||
| Maximum diameter (mm) | 38.4 ± 6.8 | 38.0 ± 6.9 | 0.99 | 38.9 ± 6.6 | 38.5 ± 6.7 | 0.99 |
| Progression (mm) | 0.5 ± 1.4 | 0.5 ± 1.2 | 0.93 | |||
| Progression (%) | 1.4 ± 3.9 | 1.4 ± 3.1 | 0.93 | |||
| Combineda | ||||||
| Maximum diameter (mm) | 41.9 ± 5.7 | 41.7 ± 5.8 | 0.99 | 42.5 ± 5.8 | 42.3 ± 5.9 | 0.99 |
| Progression (mm) | 0.6 ± 1.5 | 0.7 ± 1.5 | 0.91 | |||
| Progression (%) | 1.5 ± 3.6 | 1.6 ± 3.4 | 0.90 | |||
aIncludes both predominantly ascending and descending dilatations